Multiplex Genomics is a Canadian firm focused on developing methods that make it possible to scale up conventional COVID-19 testing and to identify the variants of this virus. Our capacity to undertake this work reflects expertise developed over the past 20 years at the Guelph’s Centre for Biodiversity Genomics, a global leader in the application of molecular methods for species identification.
Awards Winning
Complete Cases
Happy Clients
Polymerase Chain Reaction (PCR) is the gold standard for viral detection and identification.
Using Multiplex Genomics’ leading-edge detection process and automation, we can scale and process tens of thousands of tests in an 12-hour period.
Our centralized, state-of-the-art facility establishes a rigorous system of quality control for all viral pathogen testing, providing accuracy and consistency in our tests.
To get details on results, contact our media realtions, or to join our team.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor. Quisque vel lorem porttitor, malesuada arcu quis, fringilla risus. Pellentesque eu consequat augue.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue.
Read MoreOur process is built from the ground up with a focus on end-to-end data integration and scalable laboratory methods. This allows us to offer a high volume of tests without compromising on quality.
AMAVI99 adalah inovasi terbaru yang membawa terobosan dalam analisis teknologi masa depan. Dengan pemanfaatan pendekatan canggih dan solusi berbasis data, AMAVI99 memungkinkan analisis yang lebih akurat dan efisien. Terobosan ini membuka peluang baru untuk berbagai sektor, mempercepat pengambilan keputusan, dan mendukung perkembangan teknologi yang lebih maju.
>CEO & Founder
Labsky, New York, USA
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor. Quisque vel lorem porttitor, malesuada arcu quis, fringilla risus. Pellentesque eu consequat augue.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor. Quisque vel lorem porttitor, malesuada arcu quis, fringilla risus. Pellentesque eu consequat augue.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor.
More TestimonialsLorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor. Quisque vel lorem porttitor, malesuada arcu quis, fringilla risus. Pellentesque eu consequat augue.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tellus augue, iaculis id elit eget, ultrices pulvinar tortor. Quisque vel lorem porttitor, malesuada arcu quis, fringilla risus. Pellentesque eu consequat augue.
© Multiplex Genomics. All Rights Reserved.
Designed by AMAVI99